Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00024427
What this trial is testing

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganPancreatic Cancer
Wellstat Therapeutics 250
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Not applicableUnknownNCT01210872
What this trial is testing

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Georges Francois Leclerc 200
Not applicableEnded earlyNCT05029154
What this trial is testing

Exercise Preconditioning in Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Virginia 8
Testing effectiveness (Phase 2)Study completedNCT00163748
What this trial is testing

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's Disease
Bayside Health 40
Not applicableUnknownNCT04788784
What this trial is testing

Patient-Reported Outcomes HIV BItherapy

Who this might be right for
HIV/AIDS and InfectionsPatient Preference
University Paris 7 - Denis Diderot 250
Testing effectiveness (Phase 2)Looking for participantsNCT03847649
What this trial is testing

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

Who this might be right for
Cancer
Canadian Cancer Trials Group 60
Not applicableStudy completedNCT03047174
What this trial is testing

Radiotherapy Related Skin Toxicity: Mepitel® vs. Standard Care in Patients With Locally Advanced Head-and-Neck Cancer

Who this might be right for
Head and Neck Neoplasms
University Hospital Schleswig-Holstein 57
Not applicableActive Not RecruitingNCT03827343
What this trial is testing

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

Who this might be right for
Macrophage Activation SyndromePrimary Hemophagocytic Lymphohistiocytosis
National Cancer Institute (NCI) 500
Not applicableUnknownNCT05063643
What this trial is testing

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

Who this might be right for
HER2-positive Breast CancerTargeted TherapyCardiac Toxicity+1 more
Affiliated Hospital of Qinghai University 132
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Not applicableStudy completedNCT00002306
What this trial is testing

Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Large-scale testing (Phase 3)Study completedNCT00002827
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease

Who this might be right for
Cardiac ToxicityLymphoma
Children's Oncology Group 294
Large-scale testing (Phase 3)UnknownNCT05748561
What this trial is testing

Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial.

Who this might be right for
Toxic Optic NeuropathyTreatmentMethylprednisolone+1 more
Asociación para Evitar la Ceguera en México 18
Testing effectiveness (Phase 2)UnknownNCT03638375
What this trial is testing

TIL and Anti-PD1 in Metastatic Melanoma

Who this might be right for
Toxicity, DrugAdverse Drug EventEffects of Immunotherapy
Leiden University 34
Early research (Phase 1)Looking for participantsNCT07169487
What this trial is testing

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

Who this might be right for
Cytokine Release SyndromeICANS
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableLooking for participantsNCT06664528
What this trial is testing

Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies

Who this might be right for
Cardiac ToxicityCancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Post-approval studies (Phase 4)Study completedNCT02864030
What this trial is testing

PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Who this might be right for
Metastatic Breast CancerToxicityNeurotoxicity+2 more
Oncologia Medica dell'Ospedale Fatebenefratelli 200
Testing effectiveness (Phase 2)Study completedNCT00004567
What this trial is testing

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 75
Next Page